Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.22 USD | -0.16% | -0.49% | +8.02% |
05-16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
05-16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.02% | 3.43B | |
+12.05% | 128B | |
-9.24% | 10.88B | |
+0.29% | 8.76B | |
+36.99% | 5.48B | |
-21.98% | 4.72B | |
-10.32% | 2.76B | |
-12.33% | 2.06B | |
-13.53% | 1.92B | |
-28.80% | 1.65B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Truist Securities Adjusts Price Target on Axonics to $73 From $82, Maintains Buy Rating